Influence of Ultra-High Temperature Process Parameters on Age Gelation of Mille Concentrate

The purpose of this research was to investigate the effect of ultra-high temperature process parameters on age gelation of milk concentrate. Skim milk was concentrated to 2X (volume reduction) using reverse osmosis. The milk concentrate was preheated at 75 or 90°C for 20 or 50 s and UHT-processed at 138 or 145°C for 4 or 16 s. Sterilizing methods used were direct steam injection and indirect plate heat exchanger. The samples were aseptically collected in presterilized plastic containers and stored at 15 or 35°C. At 15°C storage temperature, the steam-injected samples gelled in 5 months when 4 s UHT time was used. When UHT time was increased to 16 s, the samples gelled in 6 months. Of the samples that were UHT processed by indirect plate heat exchanger for 4 s and stored at 15°C, all gelled after 7 months. When UHT time was increased to 16 s, all the 138°C samples gelled after 7 months as did the samples that were preheated for 50 s and UHT-processed at 138°C. The samples preheated at 75°C for 50 sand UHT-processed at 145°C gelled after 8 months, whereas at 90°C preheat temperature the samples gelled after 9 months. The samples stored at 35°C did not gel but showed different sedimentation levels. The sediment depth in the container was always greater for the steam-injected samples. The samples that received higher heat treatments by the two processing methods had a higher sedimentation depth. The pH decreased during storage and the extent of reduction was higher at 35°C storage temperature . Maillard browning occurred at both storage temperatures. Browning was greater in samples stored at 35°C and processed by indirect plate heat exchanger

Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial

<p>Abstract</p> <p>Background</p> <p>Type 1 diabetes mellitus (T1DM) is associated with a high risk for early atherosclerotic complications especially risk of coronary heart disease.</p> <p>Objective</p> <p>To evaluate the impact of six months exercise prgram on glycemic control, plasma lipids values, blood pressure, severity and frequency of hypoglycemia, anthropometric measurements and insulin dose in a sample of adolescents with T1DM.</p> <p>Research design and methods</p> <p>A total of 196 type 1 diabetic patients participated in the study. They were classified into three groups: Group (A) did not join the exercise program(n = 48), group (B) attended the exercise sessions once/week (n = 75), group (C) attended the exercise sessions three times/week (n = 73). Studied parameters were evaluated before and six months after exercise programe.</p> <p>Results</p> <p>Exercise improved glycemic control by reducing HbA1c values in exercise groups (P = 0.03, P = 0.01 respectively) and no change in those who were not physically active (P = 0.2). Higher levels of HbA1c were associated with higher levels of cholesterol, LDL-c, and triglycerides (P = 0.000 each). In both groups, B and C, frequent exercise improved dyslipidemia and reduced insulin requirements significantly (P = 0.00 both), as well as a reduction in BMI (P = 0.05, P = 0.00 respectively) and waist circumference(P = 0.02, P = 0.00 respectively). The frequency of hypoglycemic attacks were not statistically different between the control group and both intervention groups (4.7 ± 3.56 and 4.82 ± 4.23, P = 0.888 respectively). Reduction of blood pressure was statistically insignificant apart from the diastolic blood presure in group C (P = 0.04).</p> <p>Conclusion</p> <p>Exercise is an indispensable component in the medical treatment of patients with T1DM as it improves glycemic control and decreases cardiovascular risk factors among them.</p

Preliminary study of the efficacy of the combination of tamsulosin and trospium as a medical expulsive therapy for distal ureteric stones

Objectives: To evaluate and compare the efficacy of tamsulosin (0.4 mg, once/day) and combinations of it with trospium (20 mg, twice/day) in the treatment of single small lower ureteral stones. Patients and methods: A total of 126 patients presenting to urology outpatient clinics from July 2012 to May 2015, with a single 5–10 mm sized lower ureteral stone were randomly classified into two treatment groups. Patients in group A (n = 62) received an oral dose of 0.4 mg tamsulosin once daily and 20 mg trospium chloride twice daily. Patients in group B (n = 64) received 0.4 mg tamsulosin once daily and placebo twice daily. The spontaneous passage of stones, the stone expulsion time, and adverse effects were evaluated. Results: There were no significant differences in baseline characteristic of the patients in both groups. Stone expulsion was observed in 47 patients (75.8%), and 58 (90.62%) in groups A and B respectively. The average time to expulsion was 11.65 ± 5.32 days in group A and 17.35 ± 6.21 days in group B. The spontaneous stone passage rate through the ureter was significantly higher and the stone expulsion time was faster in groups A than in group B (p < 0.05). The adverse effects observed in both groups were comparable and were mild. Conclusions: The combination of 0.4 mg tamsulosin and 40 mg trospium as MET for single lower ureteral stones <10 mm is safe and more effective than 0.4 mg tamsulosin as a mono-therapy